|
Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A. Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing. Oncoimmunology. 2015 Oct 29;5(4):e1093721. eCollection 2016 Apr. PubMed PMID: 27141379; PubMed Central PMCID: PMC4839374.
AÑO: 2016; IF: 7.719
|
27141379
|
López-Hernández R, Campillo JA, Legaz I, Valdés M, Salama H, Boix F, Hernández-Martínez AM, Eguia J, González-Martínez G, Moya-Quiles MR, Minguela A, García-Alonso A, Carballo F, Muro M. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease. Microbiol Immunol. 2016 Nov;60(11):787-792. doi: 10.1111/1348-0421.12447. PubMed PMID: 27797112.
AÑO: 2016; IF: 1.706
|
|
Boix F, Bolarín JM, Eguía J, Gonzalez-Martinez G, De La Peña J, Galian JA, Hernández-Martínez AM, Moya-Quiles MR, Legaz I, Campillo JA, Ramirez P, Sanchez-Bueno F, García-Alonso AM, Pons JA, Minguela A, Llorente S, Muro M. Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4(+) T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients. Transplant Proc. 2016 Nov;48(9):2987-2989. doi: 10.1016/j.transproceed.2016.09.028. PubMed PMID: 27932126.
AÑO: 2016; IF: 0.908
|
|
Planelles D, Vilches C, González-Escribano F, Muro M, González-Fernández R, Sánchez F, Gonzalo Ocejo J, Eiras A, Caro JL, Palou E, Campillo JA, de Juan MD, Montes O, Balas A, Marín L, Torío A, Fernández-Arquero M, González-Roiz C, López-Vázquez A, Cisneros E, Abad-Molina C, López R, Abad-Alastruey ML, Serra C, García-Alonso AM, Vicario JL. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation. Transplant Proc. 2016 Nov;48(9):3043-3045. doi: 10.1016/j.transproceed.2016.07.037. PubMed PMID: 27932143.
AÑO: 2016; IF: 0.908
|
|
Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A. Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Am J Hematol. 2016 May 24. doi: 10.1002/ajh.24431. [Epub ahead of print] PubMed PMID: 27220360.
AÑO: 2016; IF: 5.275
|